Lento Bio Raises $680,000 in Oversubscribed Seed Round Led by Ichor Life Sciences
POTSDAM, NY / ACCESSWIRE / September 6, 2022 / Lento Bio, Inc., a preclinical pharmaceutical company developing small-molecule therapeutics to restore ocular lens flexibility and near-vision in presbyopia
Source: finanznachrichten.de